8HH Stock Overview
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Avanos Medical, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.50 |
| 52 Week High | US$28.00 |
| 52 Week Low | US$16.20 |
| Beta | 0.96 |
| 1 Month Change | 0% |
| 3 Month Change | 0.57% |
| 1 Year Change | -35.19% |
| 3 Year Change | -53.46% |
| 5 Year Change | -52.92% |
| Change since IPO | -41.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8HH | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -2.2% | -5.1% | -1.5% |
| 1Y | -35.2% | -9.0% | 0.9% |
Return vs Industry: 8HH underperformed the German Medical Equipment industry which returned -6.2% over the past year.
Return vs Market: 8HH underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| 8HH volatility | |
|---|---|
| 8HH Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8HH has not had significant price volatility in the past 3 months.
Volatility Over Time: 8HH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3,771 | Joe Woody | avanos.com |
Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems.
Avanos Medical, Inc. Fundamentals Summary
| 8HH fundamental statistics | |
|---|---|
| Market cap | €758.69m |
| Earnings (TTM) | -€9.30m |
| Revenue (TTM) | €632.57m |
1.2x
P/S Ratio-81.5x
P/E RatioIs 8HH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8HH income statement (TTM) | |
|---|---|
| Revenue | US$673.30m |
| Cost of Revenue | US$293.60m |
| Gross Profit | US$379.70m |
| Other Expenses | US$389.60m |
| Earnings | -US$9.90m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.23 |
| Gross Margin | 56.39% |
| Net Profit Margin | -1.47% |
| Debt/Equity Ratio | 13.6% |
How did 8HH perform over the long term?
See historical performance and comparison